The Relationship Between the Pharmacokinetics and Pharmacodynamic Effects of Oral Hypoglycaemic Drugs
- 1 June 1987
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 12 (6), 379-401
- https://doi.org/10.2165/00003088-198712060-00001
Abstract
Oral hypoglycaemic drugs have widely differing pharmacokinetic properties. Possible pharmacodynamic benefits include greater efficacy and fewer adverse effects. In general, it has not been possible...Keywords
This publication has 97 references indexed in Scilit:
- Type II DiabetesNew England Journal of Medicine, 1986
- Inhibition of Tolbutamide Elimination by Cimetidine but not RanitidineThe Journal of Clinical Pharmacology, 1986
- Oral Hypoglycaemic Agents An UpdateDrugs, 1984
- Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamideDiabetologia, 1980
- GlipizideDrugs, 1979
- Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic PatientsActa Medica Scandinavica, 1978
- Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamideDiabetologia, 1977
- Clinical Pharmacology of Oral Antidiabetic AgentsNew England Journal of Medicine, 1977
- Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepideDiabetologia, 1971
- Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepideDiabetologia, 1971